Triheptanoin Patent Expiration

Triheptanoin was first introduced by Ultragenyx Pharmaceutical Inc in its drug Dojolvi on Jun 30, 2020.


Triheptanoin Patents

Given below is the list of patents protecting Triheptanoin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Dojolvi US8697748 Glycogen or polysaccharide storage disease treatment method Apr 28, 2029 Ultragenyx Pharm Inc
Dojolvi US9186344 Glycogen or polysaccharide storage disease treatment method Jul 01, 2025 Ultragenyx Pharm Inc


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳